{"id":23134,"date":"2023-08-03T11:31:47","date_gmt":"2023-08-03T18:31:47","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=23134"},"modified":"2026-03-19T14:50:08","modified_gmt":"2026-03-19T21:50:08","slug":"reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/","title":{"rendered":"Reblozyl (Luspatercept): Un tratamiento eficaz para la anemia en trastornos sangu\u00edneos"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Reblozyl, tambi\u00e9n conocido por su nombre gen\u00e9rico \u201cluspatercept\u201d, es un medicamento recetado que se usa para tratar los s\u00edntomas de anemia (recuento bajo de gl\u00f3bulos rojos) en pacientes adultos que padecen trastornos sangu\u00edneos como <a href=\"https:\/\/www.cancer.gov\/types\/myeloproliferative\/patient\/myelodysplastic-treatment-pdq#:~:text=Myelodysplastic%20syndromes%20are%20a%20group,blood%20cells%20and%20bone%20marrow.\">s\u00edndrome mielodispl\u00e1sico<\/a> (MDS) y <a href=\"https:\/\/medlineplus.gov\/genetics\/condition\/beta-thalassemia\/#:~:text=Beta%20thalassemia%20is%20a%20blood,oxygen%20levels%20in%20the%20body.\">beta talasemia<\/a>.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Reblozyl pertenece a la clase de f\u00e1rmacos \u201cagentes de maduraci\u00f3n eritroide\u201d (EMA) que act\u00faan para mejorar el proceso de eritropoyesis (un proceso involucrado en la producci\u00f3n de gl\u00f3bulos rojos maduros). <\/span><span style=\"font-weight: 400;\">En otras palabras, funciona creando gl\u00f3bulos rojos (GR) m\u00e1s maduros y funcionales, y permite que las c\u00e9lulas inmaduras maduren y funcionen correctamente. Esto mejora la calidad de los GR y aumenta la cantidad de hemoglobina (Hb) en el organismo, lo que resulta en una mejora de la anemia debido a la mayor cantidad de GR maduros en el torrente sangu\u00edneo.<\/span><span style=\"font-weight: 400;\"> Reblozyl es el \u00fanico f\u00e1rmaco de esta clase que <\/span><span style=\"font-weight: 400;\">est\u00e1 aprobado por la FDA<\/span><span style=\"font-weight: 400;\"> para el tratamiento de la anemia en pacientes adultos que requieren transfusiones regulares de gl\u00f3bulos rojos o cuya anemia no responde bien a otros agentes de maduraci\u00f3n eritroide.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Reblozyl s\u00f3lo puede obtenerse con receta m\u00e9dica y est\u00e1 disponible en viales de dosis \u00fanica para inyecci\u00f3n en dos concentraciones diferentes: 25 mg y 75 mg.&nbsp;<\/span><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#What_Is_Reblozyl_Used_To_Treat\" >\u00bfPara qu\u00e9 se utiliza el Reblozyl?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#How_Does_Reblozyl_Work\" >\u00bfC\u00f3mo funciona Reblozyl?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#Dosage_Form_and_Strength\" >Forma farmac\u00e9utica y concentraci\u00f3n<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#Reconstitution_of_Reblozyl_Powder_in_Sterile_Water\" >Reconstituci\u00f3n del polvo Reblozyl en agua est\u00e9ril&nbsp;<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#Reblozyl_Dosing_Information\" >Informaci\u00f3n de dosificaci\u00f3n de Reblozyl<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#Dose_Modification_for_B-thalassemia_Patients\" >Modificaci\u00f3n de la dosis para pacientes con B-talasemia&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#Dose_Modification_for_MDS_Patients\" >Modificaci\u00f3n de la dosis para pacientes con SMD&nbsp;<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#How_Is_Reblozyl_Given\" >\u00bfC\u00f3mo se administra Reblozyl?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#Is_Reblozyl_a_Form_of_Chemotherapy\" >\u00bfEs Reblozyl una forma de quimioterapia?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#Possible_Side_Effects_of_Reblozyl\" >Posibles efectos secundarios de Reblozyl<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#Precaution\" >Precauci\u00f3n<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#Cost\" >Costo<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Reblozyl_Used_To_Treat\"><\/span>\u00bfPara qu\u00e9 se utiliza el Reblozyl?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Reblozyl ha sido aprobado como terapia de primera clase para tratar la anemia asociada con los siguientes trastornos sangu\u00edneos en adultos:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><b>Beta talasemia \u2013 <\/b><span style=\"font-weight: 400;\">Un tipo raro de trastorno sangu\u00edneo hereditario en el que los pacientes presentan genes ausentes o defectuosos que producen la prote\u00edna beta globina. Esta prote\u00edna es un componente de la hemoglobina presente en los gl\u00f3bulos rojos (RBC) y transporta ox\u00edgeno por todo el cuerpo. <\/span><span style=\"font-weight: 400;\">Cuando usted tiene talasemia, su cuerpo produce menos hemoglobina de lo normal y esto puede provocar anemia leve o grave.<\/span><span style=\"font-weight: 400;\"> Cuando los niveles de hemoglobina son bajos, puede causar debilidad muscular, fatiga y muchas m\u00e1s complicaciones graves. <\/span><span style=\"font-weight: 400;\">Reblozyl est\u00e1 indicado en pacientes adultos con beta talasemia que requieren transfusiones regulares de gl\u00f3bulos rojos.&nbsp;<\/span><\/li>\n\n\n\n<li><b>S\u00edndrome mielodispl\u00e1sico (SMD) <\/b><span style=\"font-weight: 400;\">Un grupo de c\u00e1nceres en los que las c\u00e9lulas hematopoy\u00e9ticas inmaduras de la m\u00e9dula \u00f3sea no se desarrollan (maduran) ni se convierten en c\u00e9lulas sanas y funcionales. Las c\u00e9lulas m\u00e1s com\u00fanmente afectadas por el SMD son los gl\u00f3bulos rojos. <\/span><span style=\"font-weight: 400;\">Cuando las c\u00e9lulas inmaduras no funcionan correctamente, se reduce el espacio para la formaci\u00f3n de gl\u00f3bulos blancos (GB), gl\u00f3bulos rojos (GR) y plaquetas sanos en la m\u00e9dula \u00f3sea. La disminuci\u00f3n de gl\u00f3bulos rojos sanos puede provocar anemia, infecciones o hemorragias frecuentes.&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<p>Pacientes diagnosticados con SMD o sus subtipos llamados neoplasia mielodispl\u00e1sica\/mieloproliferativa con <a href=\"https:\/\/ashpublications.org\/blood\/article\/119\/24\/5674\/30309\/Prognostic-irrelevance-of-ring-sideroblast\">sideroblastos en anillo<\/a> (SMD-RS) o con anemia asociada a trombocitosis que no han respondido a un tratamiento <a href=\"https:\/\/en.wikipedia.org\/wiki\/Erythropoiesis-stimulating_agent\">agente estimulante de la eritropoyesis<\/a> (EPO) y requieren dos o m\u00e1s unidades de gl\u00f3bulos rojos (para transfusi\u00f3n) durante 8 semanas pueden ser elegibles para recibir el tratamiento con Rebloyzl.<br><b><\/b><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">El prop\u00f3sito de utilizar Reblozyl en pacientes con los trastornos mencionados anteriormente es reducir el n\u00famero de transfusiones de sangre y las complicaciones asociadas a las transfusiones. <\/span><span style=\"font-weight: 400;\">Sin embargo, es importante se\u00f1alar que el Reblozyl no debe utilizarse como sustituto de las transfusiones de gl\u00f3bulos rojos en pacientes que requieren correcci\u00f3n inmediata de la anemia. Tampoco se sabe si el Reblozyl es eficaz o seguro en menores de 18 a\u00f1os.<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Does_Reblozyl_Work\"><\/span>\u00bfC\u00f3mo funciona Reblozyl?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">En circunstancias normales, los gl\u00f3bulos rojos inmaduros maduran y se convierten en c\u00e9lulas sanas y funcionales dentro de la m\u00e9dula \u00f3sea mediante el proceso de eritropoyesis. La eritropoyesis es un proceso din\u00e1mico que comienza con la proliferaci\u00f3n de... <a href=\"https:\/\/profiles.umassmed.edu\/display\/106571#:~:text=The%20cells%20in%20the%20erythroid,to%20mature%20RED%20BLOOD%20CELLS.\">precursores eritroides<\/a> Y culmina con la maduraci\u00f3n de los gl\u00f3bulos rojos sanos en la m\u00e9dula \u00f3sea. Los gl\u00f3bulos rojos maduros pasan entonces a la circulaci\u00f3n sangu\u00ednea y desempe\u00f1an su funci\u00f3n de transportar ox\u00edgeno por todo el cuerpo.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">La eritropoyesis ineficaz da como resultado un recuento de gl\u00f3bulos rojos m\u00e1s bajo y <\/span><span style=\"font-weight: 400;\">un riesgo mayor<\/span><span style=\"font-weight: 400;\"> La eritropoyesis ineficaz se produce debido a la hiperactividad de la v\u00eda de se\u00f1alizaci\u00f3n Smad2\/3, que ralentiza o detiene la maduraci\u00f3n normal de los gl\u00f3bulos rojos en pacientes con B-talasemia y SMD.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Reblozyl, tambi\u00e9n conocido por su nombre gen\u00e9rico: <\/span><b>\u201c<\/b><b>luspatercept\u201d,<\/b> <span style=\"font-weight: 400;\">i<\/span><span style=\"font-weight: 400;\">su recombinante <\/span><span style=\"font-weight: 400;\">fusi\u00f3n<\/span><span style=\"font-weight: 400;\"> prote\u00edna que <\/span><span style=\"font-weight: 400;\">enlaza seleccionado <a href=\"https:\/\/www.rndsystems.com\/research-area\/tgf--beta-superfamily\">factor de crecimiento transformante<\/a><\/span><span style=\"font-weight: 400;\">Ligandos de la superfamilia \u03b2 (TGF-\u03b2). Cuando se une a ligandos end\u00f3genos espec\u00edficos, bloquea la se\u00f1alizaci\u00f3n de Smad2\/3, lo que provoca la maduraci\u00f3n eritroide en la m\u00e9dula \u00f3sea y conduce a...<\/span><span style=\"font-weight: 400;\"> el desarrollo normal de los gl\u00f3bulos rojos.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dosage_Form_and_Strength\"><\/span>Forma farmac\u00e9utica y concentraci\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Reblozyl viene en forma de polvo liofilizado est\u00e9ril, de color blanco a blanquecino, en concentraciones de 25 mg y 75 mg.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reconstitution_of_Reblozyl_Powder_in_Sterile_Water\"><\/span><b>Reconstituci\u00f3n del polvo Reblozyl en agua est\u00e9ril&nbsp;<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Un vial monodosis de 25 mg se reconstituye con 0,68 ml de agua est\u00e9ril. <\/span><span style=\"font-weight: 400;\">Cada vial de dosis \u00fanica de 25 mg liberar\u00e1 al menos 0,5 ml de 50 mg\/ml de luspatercept.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Un vial monodosis de 75 mg se reconstituye con 1,6 ml de agua est\u00e9ril. <\/span><span style=\"font-weight: 400;\">Cada vial de dosis \u00fanica de 75 mg liberar\u00e1 al menos 1,5 ml de 50 mg\/ml de luspatercept.<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Se debe utilizar una jeringa con marcas de graduaci\u00f3n para administrar dosis precisas.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Reblozyl_Dosing_Information\"><\/span>Informaci\u00f3n de dosificaci\u00f3n de Reblozyl<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">La dosis de Reblozyl se ajusta seg\u00fan el peso corporal, la hemoglobina y el historial transfusional del paciente. La dosis inicial recomendada es de 1 mg\/kg una vez cada 3 semanas.&nbsp;<\/span><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dose_Modification_for_B-thalassemia_Patients\"><\/span><b>Modificaci\u00f3n de la dosis para pacientes con B-talasemia&nbsp;<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Las dosis futuras se modifican en las siguientes condiciones:&nbsp;<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Si el paciente muestra una respuesta insuficiente a la dosis inicial (1 mg\/kg <\/span><span style=\"font-weight: 400;\">una vez cada 3 semanas<\/span><span style=\"font-weight: 400;\">) y no se consigue una reducci\u00f3n de las transfusiones de gl\u00f3bulos rojos despu\u00e9s de dos tratamientos (al menos 2 dosis consecutivas\/6 semanas), la dosis se puede aumentar a 1,25 mg\/kg una vez cada 3 semanas. <\/span><span style=\"font-weight: 400;\">(dosis m\u00e1xima)<\/span><span style=\"font-weight: 400;\">.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Interrumpir el tratamiento si los pacientes muestran una respuesta insuficiente a la dosis modificada (1,25 mg\/kg) y no logran una reducci\u00f3n en las transfusiones de gl\u00f3bulos rojos despu\u00e9s de tres tratamientos (3 dosis\/9 semanas).&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dose_Modification_for_MDS_Patients\"><\/span><b>Modificaci\u00f3n de la dosis para pacientes con SMD&nbsp;<\/b><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p><span style=\"font-weight: 400;\">Las dosis futuras se modifican en las siguientes condiciones:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Si el paciente muestra una respuesta insuficiente a la dosis inicial (1 mg\/kg) y no logra una reducci\u00f3n en las transfusiones de gl\u00f3bulos rojos despu\u00e9s de dos tratamientos (2 dosis\/6 semanas), aumente la dosis a 1,33 mg\/kg una vez cada 3 semanas.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Si los pacientes muestran una respuesta insuficiente a la dosis modificada (1,33 mg\/kg) y no logran una reducci\u00f3n en las transfusiones de gl\u00f3bulos rojos despu\u00e9s de dos tratamientos (2 dosis\/6 semanas), aumente la dosis a 1,75 mg\/kg una vez cada 3 semanas.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Suspender el tratamiento si los pacientes muestran una respuesta insuficiente a la dosis modificada (1,75 mg\/kg) y no logran una reducci\u00f3n en las transfusiones de gl\u00f3bulos rojos despu\u00e9s de tres tratamientos (3 dosis\/9 semanas).&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_Is_Reblozyl_Given\"><\/span>\u00bfC\u00f3mo se administra Reblozyl?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">El medicamento Reblozyl s\u00f3lo se administra <a href=\"https:\/\/ameripharmaspecialty.com\/es\/ivig\/scig-vs-ivig\/\">por v\u00eda subcut\u00e1nea<\/a> (debajo de la piel) una vez cada tres semanas.&nbsp;<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Recibir\u00e1 una inyecci\u00f3n de Reblozyl bajo la piel del abdomen, la parte superior de los brazos o los muslos. Este medicamento se inyectar\u00e1 bajo la supervisi\u00f3n de un profesional de la salud o una enfermera con experiencia para evitar complicaciones posteriores.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Is_Reblozyl_a_Form_of_Chemotherapy\"><\/span>\u00bfEs Reblozyl una forma de quimioterapia?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">Reblozyl no es una forma de quimioterapia, sino un medicamento recetado que se usa para tratar la anemia asociada con SMD y beta talasemia en adultos.&nbsp;<\/span><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Possible_Side_Effects_of_Reblozyl\"><\/span>Posibles efectos secundarios de Reblozyl<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/woman-stomach-pain.jpg\" alt=\"Asian woman feeling stomachache as a side effect of Reblozyl\" class=\"wp-image-23137\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/woman-stomach-pain.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/woman-stomach-pain-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/woman-stomach-pain-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/woman-stomach-pain-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/woman-stomach-pain-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/woman-stomach-pain-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/woman-stomach-pain-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p><span style=\"font-weight: 400;\">Los efectos secundarios m\u00e1s comunes de Reblozyl incluyen<\/span><span style=\"font-weight: 400;\">:&nbsp;<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Sentirse cansado<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dolor muscular o \u00f3seo<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Mareo<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Diarrea<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dolor de est\u00f3mago (abdominal)<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Reacciones al\u00e9rgicas<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dolor de cabeza<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dolor articular (artralgia)<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">N\u00e1useas<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Tos<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Signos de un resfriado com\u00fan<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">S\u00edntomas parecidos a los de la gripe<\/span><\/li>\n<\/ul>\n\n\n\n<p><span style=\"font-weight: 400;\">Algunos efectos secundarios graves que pueden ocurrir incluyen:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Co\u00e1gulos de sangre (trombosis\/tromboembolia)<\/span>\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">El riesgo puede ser mayor en personas a quienes se les ha extirpado el bazo o que toman p\u00edldoras anticonceptivas o terapia de reemplazo hormonal.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Es importante llamar a su proveedor de atenci\u00f3n m\u00e9dica o buscar ayuda m\u00e9dica de inmediato si experimenta alguno de estos s\u00edntomas:<\/span>\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Dolor en el pecho<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dificultad para respirar o falta de aire<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dolor en la pierna, con o sin hinchaz\u00f3n.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Un brazo o una pierna p\u00e1lidos o fr\u00edos<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Entumecimiento o debilidad repentinos que duran poco tiempo o contin\u00faan durante un per\u00edodo prolongado, especialmente si se presentan en un lado del cuerpo.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Dolor de cabeza intenso o confusi\u00f3n<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Mareos repentinos o dificultad para ver, caminar, hablar o mantener el equilibrio.&nbsp;<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Presi\u00f3n arterial alta (hipertensi\u00f3n)<\/span>\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Su proveedor controlar\u00e1 su presi\u00f3n arterial antes de recibir su dosis de Reblozyl<\/span><\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><span style=\"font-weight: 400;\"><a href=\"https:\/\/radiopaedia.org\/articles\/extramedullary-haematopoiesis?lang=us\">Hematopoy\u00e9tica extramedular (HME)<\/a> masas<\/span>\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Es importante llamar a su proveedor de atenci\u00f3n m\u00e9dica o buscar ayuda m\u00e9dica de inmediato si experimenta alguno de estos s\u00edntomas:<\/span>\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Dolor de espalda severo<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Entumecimiento, debilidad o p\u00e9rdida del movimiento voluntario en las piernas, brazos, manos o pies.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">P\u00e9rdida del control de los intestinos y la vejiga&nbsp;<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Precaution\"><\/span>Precauci\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">La terapia con Reblozyl no es para todos. Debe consultar con su profesional de la salud antes de tomarla si:<\/span><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><span style=\"font-weight: 400;\">Son <\/span><b>embarazada<\/b><span style=\"font-weight: 400;\">El Reblozyl puede causar da\u00f1o fetal. Por lo tanto, se recomienda evitar el tratamiento con Reblozyl durante el embarazo.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Son <\/span><b>planeando quedar embarazada<\/b><span style=\"font-weight: 400;\">Utilice un m\u00e9todo anticonceptivo eficaz durante el tratamiento. <\/span><span style=\"font-weight: 400;\">y durante al menos 3 meses despu\u00e9s de la dosis final.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Son<\/span><b> amamantando o planea amamantar<\/b><span style=\"font-weight: 400;\">Dado que los datos sobre la presencia de Reblozyl en la leche materna humana son limitados, no se recomienda amamantar mientras se reciben inyecciones de Reblozyl y <\/span><span style=\"font-weight: 400;\">durante al menos 3 meses despu\u00e9s de la dosis final.&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Es al\u00e9rgico a cualquier componente de Reblozyl.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Tiene o ha tenido antecedentes de hipertensi\u00f3n y <\/span><span style=\"font-weight: 400;\">masas hematopoy\u00e9ticas extramedulares (HME).&nbsp;<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Me hicieron una esplenectom\u00eda (extirpaci\u00f3n del bazo).<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Tiene o ha tenido el bazo o el h\u00edgado agrandados.<\/span><\/li>\n\n\n\n<li><span style=\"font-weight: 400;\">Tome multivitam\u00ednicos, suplementos a base de hierbas o medicamentos de venta libre.&nbsp;<\/span><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cost\"><\/span>Costo<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><span style=\"font-weight: 400;\">El costo de este medicamento puede variar seg\u00fan la farmacia a la que acuda. Por favor <a href=\"https:\/\/ameripharmaspecialty.com\/es\/financial-assistance\/\">Cont\u00e1ctanos<\/a> Si est\u00e1 interesado en obtener asistencia con el copago para Reblozyl.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>Reblozyl, tambi\u00e9n conocido por su nombre gen\u00e9rico \u201cluspatercept\u201d, es un medicamento recetado que se usa para tratar los s\u00edntomas de anemia (recuento bajo de gl\u00f3bulos rojos) en pacientes adultos que padecen trastornos sangu\u00edneos como el s\u00edndrome mielodispl\u00e1sico (SMD) y la beta talasemia.\u00a0<\/p>","protected":false},"author":28,"featured_media":23135,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[64],"tags":[34],"class_list":["post-23134","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-discontinued","tag-dr-jenna-nguyen"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Reblozyl (Luspatercept): An Effective Treatment for Anemia in Blood Disorders - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn about Reblozyl and how it treats anemia. Topics include how the drug works, dosing information, side effects, and cost.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Reblozyl (Luspatercept): An Effective Treatment for Anemia in Blood Disorders - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Learn about Reblozyl and how it treats anemia. Topics include how the drug works, dosing information, side effects, and cost.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-03T18:31:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-19T21:50:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Jenna Nguyen, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Jenna Nguyen, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\\\/\"},\"author\":{\"name\":\"Dr. Jenna Nguyen, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/person\\\/233222f53208e12fe8542ac3e8a472cc\"},\"headline\":\"Reblozyl (Luspatercept): An Effective Treatment for Anemia in Blood Disorders\",\"datePublished\":\"2023-08-03T18:31:47+00:00\",\"dateModified\":\"2026-03-19T21:50:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\\\/\"},\"wordCount\":1475,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/redbloodcells.jpg\",\"keywords\":[\"Dr. Jenna Nguyen\"],\"articleSection\":[\"Discontinued\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\\\/\",\"name\":\"Reblozyl (Luspatercept): An Effective Treatment for Anemia in Blood Disorders - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/redbloodcells.jpg\",\"datePublished\":\"2023-08-03T18:31:47+00:00\",\"dateModified\":\"2026-03-19T21:50:08+00:00\",\"description\":\"Learn about Reblozyl and how it treats anemia. Topics include how the drug works, dosing information, side effects, and cost.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/redbloodcells.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/redbloodcells.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Blood cells under a microscope, 3d render\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/discontinued\\\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Reblozyl (Luspatercept): An Effective Treatment for Anemia in Blood Disorders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/person\\\/233222f53208e12fe8542ac3e8a472cc\",\"name\":\"Dr. Jenna Nguyen, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/14905a206e443dcf31035c117ffb8484c19036db1c76ce36cfc39b3dd936e03d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/14905a206e443dcf31035c117ffb8484c19036db1c76ce36cfc39b3dd936e03d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/14905a206e443dcf31035c117ffb8484c19036db1c76ce36cfc39b3dd936e03d?s=96&d=mm&r=g\",\"caption\":\"Dr. Jenna Nguyen, PharmD\"},\"description\":\"Dr. Jenna Nguyen, PharmD, was born and raised in Anaheim, CA. She studied at Midwestern University, and was the Industry Pharmacists Organization (IPhO) President from 2020 - 2021. The most rewarding part of her job is communicating with patients, hearing their concerns, and helping them in the best way possible. Dr. Nguyen lives an active lifestyle, and in her free time,\u00a0 she enjoys strength training and exercising four to five times a week.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/jenna\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Reblozyl (Luspatercept): Un tratamiento eficaz para la anemia en trastornos sangu\u00edneos - AmeriPharma\u00ae Atenci\u00f3n especializada","description":"Aprenda sobre el Reblozyl y c\u00f3mo trata la anemia. Los temas incluyen c\u00f3mo funciona el medicamento, informaci\u00f3n sobre la dosificaci\u00f3n, efectos secundarios y costo.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/","og_locale":"es_MX","og_type":"article","og_title":"Reblozyl (Luspatercept): An Effective Treatment for Anemia in Blood Disorders - AmeriPharma\u00ae Specialty Care","og_description":"Learn about Reblozyl and how it treats anemia. Topics include how the drug works, dosing information, side effects, and cost.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2023-08-03T18:31:47+00:00","article_modified_time":"2026-03-19T21:50:08+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg","type":"image\/jpeg"}],"author":"Dr. Jenna Nguyen, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Jenna Nguyen, PharmD","Est. reading time":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/"},"author":{"name":"Dr. Jenna Nguyen, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/person\/233222f53208e12fe8542ac3e8a472cc"},"headline":"Reblozyl (Luspatercept): An Effective Treatment for Anemia in Blood Disorders","datePublished":"2023-08-03T18:31:47+00:00","dateModified":"2026-03-19T21:50:08+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/"},"wordCount":1475,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg","keywords":["Dr. Jenna Nguyen"],"articleSection":["Discontinued"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/","url":"https:\/\/ameripharmaspecialty.com\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/","name":"Reblozyl (Luspatercept): Un tratamiento eficaz para la anemia en trastornos sangu\u00edneos - AmeriPharma\u00ae Atenci\u00f3n especializada","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg","datePublished":"2023-08-03T18:31:47+00:00","dateModified":"2026-03-19T21:50:08+00:00","description":"Aprenda sobre el Reblozyl y c\u00f3mo trata la anemia. Los temas incluyen c\u00f3mo funciona el medicamento, informaci\u00f3n sobre la dosificaci\u00f3n, efectos secundarios y costo.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg","width":1280,"height":853,"caption":"Blood cells under a microscope, 3d render"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/discontinued\/reblozyl-luspatercept-an-effective-treatment-for-anemia-in-blood-disorders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/vi\/"},{"@type":"ListItem","position":2,"name":"Reblozyl (Luspatercept): An Effective Treatment for Anemia in Blood Disorders"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#website","url":"https:\/\/ameripharmaspecialty.com\/vi\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/vi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/vi\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/person\/233222f53208e12fe8542ac3e8a472cc","name":"Dra. Jenna Nguyen, Farmac\u00e9utica","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/14905a206e443dcf31035c117ffb8484c19036db1c76ce36cfc39b3dd936e03d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/14905a206e443dcf31035c117ffb8484c19036db1c76ce36cfc39b3dd936e03d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/14905a206e443dcf31035c117ffb8484c19036db1c76ce36cfc39b3dd936e03d?s=96&d=mm&r=g","caption":"Dr. Jenna Nguyen, PharmD"},"description":"La Dra. Jenna Nguyen, doctora en farmacia, naci\u00f3 y creci\u00f3 en Anaheim, California. Estudi\u00f3 en la Universidad Midwestern y fue presidenta de la Organizaci\u00f3n de Farmac\u00e9uticos de la Industria (IPhO) de 2020 a 2021. Lo m\u00e1s gratificante de su trabajo es comunicarse con los pacientes, escuchar sus inquietudes y ayudarlos de la mejor manera posible. La Dra. Nguyen lleva un estilo de vida activo y, en su tiempo libre, disfruta del entrenamiento de fuerza y el ejercicio cuatro o cinco veces por semana.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/jenna\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Jenna Nguyen, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/jenna\/"},"uagb_comment_info":0,"uagb_excerpt":"Reblozyl, also known by its generic name \"luspatercept,\" is a prescription drug used to treat symptoms of anemia (low red blood cell counts) in adult patients suffering from blood disorders such as myelodysplastic syndrome (MDS) and beta thalassemia.\u00a0","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg",600,400,false],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2023\/08\/redbloodcells.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Jenna Nguyen, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/jenna\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/discontinued\/\" rel=\"category tag\">Discontinued<\/a>","rttpg_excerpt":"Reblozyl, also known by its generic name \"luspatercept,\" is a prescription drug used to treat symptoms of anemia (low red blood cell counts) in adult patients suffering from blood disorders such as myelodysplastic syndrome (MDS) and beta thalassemia.\u00a0","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=23134"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/23134\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/23135"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=23134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=23134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=23134"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}